Mythili Pathipati, MD
Gastroenterology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pathipati’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$3,354
Medicare paid this office $3,354 for 19 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Colonoscopy | 25 | More than 51% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 16 | More than 47% of doctors who do this |
Who their Medicare patients are
19 Original Medicare patients in 2024. Average age 80 · Under 65 0% · Also on Medicaid 0% · Health risk score 0.86. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
The office billed $13,002, Medicare allowed $4,191 and paid $3,354; for 22 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$41,940
Pharmacies billed $41,940 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 197) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
148 generic and fewer than 11 brand-name prescriptions · $41,940 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Motegrity | 11 | $15,189 | $1,381 |
| Linzess | 15 | $7,764 | $518 |
| Gabapentin | 26 | $517 | $20 |
| Famotidine | 16 | $293 | $18 |
| Omeprazole | 27 | $252 | $9 |
See all 6 drugs
| Motegrity | 11 | $15,189 | $1,381 |
| Linzess | 15 | $7,764 | $518 |
| Gabapentin | 26 | $517 | $20 |
| Famotidine | 16 | $293 | $18 |
| Omeprazole | 27 | $252 | $9 |
| Nortriptyline | 11 | $79 | $7 |
Year by year
| 2024 | 197 | 39 | 0% (0) | None | $41,940 |
| 2023 | 273 | 50 | 0% (0) | None | $218,095 |
| 2022 | 137 | 32 | 0% (0) | 28% | $44,484 |
| 2021 | 274 | 40 | None | 19% | $41,132 |
| 2020 | 369 | 68 | 5% (17) | None | $37,668 |
| 2019 | 348 | 59 | 12% (41) | None | $28,078 |
| 2018 | 97 | 13 | 19% (18) | 21% | $6,463 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Sandostatin Lar Depot | 21 | $148,409 | $7,067 |
| Motegrity | 23 | $24,711 | $1,074 |
| Creon | 18 | $23,972 | $1,332 |
| Linzess | 11 | $5,954 | $541 |
| Gabapentin | 34 | $1,061 | $31 |
| Omeprazole | 33 | $644 | $20 |
| Trazodone | 15 | $324 | $22 |
| Nortriptyline | 11 | $260 | $24 |
| Dicyclomine | 12 | $174 | $15 |
2022: 3 drugs
| Creon | 12 | $8,715 | $726 |
| Motegrity | 11 | $7,676 | $698 |
| Omeprazole | 34 | $680 | $20 |
2021: 6 drugs
| Duloxetine | 18 | $1,737 | $96 |
| Omeprazole | 23 | $399 | $17 |
| Gabapentin | 22 | $323 | $15 |
| Cyclobenzaprine | 19 | $309 | $16 |
| Atorvastatin | 14 | $293 | $21 |
| Amlodipine Besylate | 14 | $71 | $5 |
2020: 8 drugs
| Duloxetine | 24 | $1,093 | $46 |
| Pregabalin | 12 | $922 | $77 |
| Metoprolol | 11 | $435 | $40 |
| Gabapentin | 19 | $385 | $20 |
| Omeprazole | 27 | $270 | $10 |
| Cyclobenzaprine | 22 | $200 | $9 |
| Furosemide | 16 | $164 | $10 |
| Atorvastatin | 13 | $94 | $7 |
2019: 8 drugs
| Duloxetine | 14 | $1,025 | $73 |
| Oxycodone | 12 | $436 | $36 |
| Metoprolol | 11 | $389 | $35 |
| Omeprazole | 21 | $311 | $15 |
| Atorvastatin | 18 | $291 | $16 |
| Cyclobenzaprine | 29 | $197 | $7 |
| Metformin | 14 | $97 | $7 |
| Amlodipine Besylate | 15 | $46 | $3 |
2018: 1 drug
| Atorvastatin | 11 | $156 | $14 |
Money from drug and device companies
$420 in 2025
| 2025 | 3 | 8 | None | $420 |
| 2024 | 1 | 1 | None | $122 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $192 | 4 payments
|
| Abbvie | Skyrizi | $125 | 1 payment
|
| Lilly USA | Omvoh | $103 | 3 payments
|
See all 8 published payments
| Janssen Biotech | Meals · 2025-08-27 | Tremfya | $30 |
| Janssen Biotech | Meals · 2025-08-13 | Tremfya | $22 |
| Janssen Biotech | Education · 2025-07-02 | Tremfya | $99 |
| Lilly USA | Meals · 2025-06-24 | Omvoh | $33 |
| Janssen Biotech | Meals · 2025-06-17 | Tremfya | $41 |
| Abbvie | Meals · 2025-06-05 | Skyrizi | $125 |
| Lilly USA | Meals · 2025-04-28 | Omvoh | $35 |
| Lilly USA | Meals · 2025-04-01 | Omvoh | $35 |
See earlier years (2024)
2024: $122
| Janssen Biotech | Tremfya | $122 | 1 payment
|
Professional record
- NPI
- 1306336490
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2018-05-14
- NPI last updated
- 2024-09-24
- NPI record certified
- 2024-09-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 55 Fruit St, Boston, MA, 02114